Kiwamu Saito

Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI

Atsushi Kaneko, Daihei Kida, Kiwamu Saito et al. · Rheumatology International · 2011 · 26 citations

Medicine, Clinical Sciences, Pharmacotherapy +5

Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use

Nobunori Takahashi, Takayoshi Fujibayashi, Daihei Kida et al. · Rheumatology International · 2015 · 20 citations

Life Sciences, Immunology, Pharmacotherapy +15

Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate

Tomonori Kobayakawa, Toshihisa Kojima, Nobunori Takahashi et al. · Modern Rheumatology · 2014 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Disease activity early in treatment as a predictor of future low disease activity in RA patients treated with iguratimod

Yutaka Yoshioka, Nobunori Takahashi, Atsushi Kaneko et al. · Modern Rheumatology · 2015 · 15 citations

Medicine, Clinical Sciences, Pharmacotherapy +14